Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [14854]

Drugs already licensed could be trialled to potentially treat secondary brain cancer

Drugs already licensed could be trialled to potentially treat secondary brain cancer

FDA approves nirogacestat for desmoid tumours

FDA approves nirogacestat for desmoid tumours

Colorectal cancer in sub-Saharan Africa: Lack of basic care is costing lives

Colorectal cancer in sub-Saharan Africa: Lack of basic care is costing lives

Lidocaine may be able to kill certain cancer cells by activating bitter taste receptors

Lidocaine may be able to kill certain cancer cells by activating bitter taste receptors

Robust chromatin map explains heterogeneity of paediatric acute lymphoblastic leukaemia

Robust chromatin map explains heterogeneity of paediatric acute lymphoblastic leukaemia

Research finds correlation between biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy

Research finds correlation between biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy

Liver cancer rates increase in each successive generation of Mexican Americans, study finds

Liver cancer rates increase in each successive generation of Mexican Americans, study finds

Immunotherapy drug is well tolerated in lung cancer patients with limited physical function, study suggests

Immunotherapy drug is well tolerated in lung cancer patients with limited physical function, study suggests

Obesity may not be the only factor to link ultra-processed foods to higher risk of mouth, throat and oesophagus cancers

Obesity may not be the only factor to link ultra-processed foods to higher risk of mouth, throat and oesophagus...

FDA approves repotrectinib for ROS1-positive non-small cell lung cance

FDA approves repotrectinib for ROS1-positive non-small cell lung cance

More from ecancer